Black Hawk Acquisition Corp (BKHA) stock
BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
$8.65+1.45 (+20.14%)
Close on Nov 17, 2026Market cap $35.93MP/E –Yield –
Black Hawk Acquisition cash
Cash and short-term investments held at the end of each period.
Black Hawk Acquisition's cash was $0 at Aug 31, 2026. For fiscal 2025 it was $0, down 100.0% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $0 | -100.0% |
| FY2024 | Nov 30, 2024 | $264.84K | +111.7% |
| FY2023 | Nov 30, 2023 | $125.10K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | $0 | -100.0% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $0 | -100.0% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $0 | -100.0% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | $0 | -100.0% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $15.00K | -95.4% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $72.91K | -80.1% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $101.53K | +70.9% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $264.84K | +111.7% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $323.85K | – |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $366.67K | – |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | $59.40K | – |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | $125.10K | – |
See a number that looks wrong?